POLARIS: A Phase 2 Trial of Encorafenib Plus Binimetinib Evaluating High-Dose and Standard-Dose Regimens in Patients with BRAF V600-mutant Melanoma with Brain Metastasis
NEURO-ONCOLOGY ADVANCES(2024)
关键词
Binimetinib,BRAF V600,Encorafenib,Melanoma,POLARIS
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要